PHARMACEUTICAL IP

Evolve Insights

Welcome to Evolve Insights!

Evolve Insights is your go-to source for expert analysis and strategic perspectives on pharmaceutical IP.

  • Read our Articles for the latest pharma IP news and analysis. Many of our articles were originally published on IPKat.
  • Register for our upcoming live Webinars and watch our previous webinars on-demand.
  • Subscribe to our newsletter to stay up to date.

Do you have questions about how the latest developments in IP might impact you? Our team of experts would love to hear from you.

Latest articles

All articles

Claim construction checkpoints: Application as filed versus granted patent (T 0715/24)

G 1/24 requires that the description must always be “consulted” to interpret a claim. The question remains whether a definition in the description can override an otherwise clear meaning in the claims. In T 0715/24, Bristol-Myers Squibb (BMS) sought to persuade the Board of Appeal that a negative feature, read together with a paragraph of…

Evolve Intellectual Property ranked in IAM Patent 1000

We are proud to announce that Evolve IP has been ranked in the 2026 publication of the IAM Patent 1000: United Kingdom – England and Wales. This year’s guide highlights our deep technical expertise in life sciences and our practical, strategic business focus. Congratulations to our patent attorneys, Steven Gurney who is ranked Silver and Rose…

IP Stars: Evolve recognised in 2026 Publication

We are delighted to announce that Evolve IP has been recognised in the 2026 IP STARS rankings. This distinction reflects our team’s ongoing dedication to exceptional intellectual property support, featuring key individual accolades for our patent attorneys. Steven Gurney has been recognised as a Patent Star. This specific ranking is awarded to senior practitioners who demonstrate proven excellence in…

Webinars

All webinars
  • In person event

In-person event: Festive EPO pharma case law 2025 round-up

Upcoming date: December 17, 2025, 4:00 pm GMT
Join us for a wrap up review of the key pharma EPO caselaw in 2025 and a look ahead to 2026 alongside some mince pies and festive cheer.
  • On-demand

EPO pharma case law 2025: Everything you need to know!

Recorded on: December 12, 2025
Key pharma IP trends, landmark EPO decisions, and strategic advice for IP professionals.
  • On-demand

Securing return of investment: Understanding how large pharma companies think about IP

Recorded on: September 19, 2025
Learn how large pharmaceutical companies think about IP strategy.

Stay connected

Get the latest insights, news, and expert analysis on pharmaceutical IP delivered straight to your inbox.
Subscribe for updates